comprehensive
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: House looks to weaken Medicare negotiation
Next article: House looks to weaken Medicare negotiation
leisure time
entertainment
-
Readout Newsletter: Ironwood, Pfizer, FogPharma updates
2025-09-29 20:18 -
AstraZeneca loses challenge to Medicare drug price negotiation
2025-09-29 20:00 -
Asahi Kasei to buy Calliditas, picking up kidney disease drug
2025-09-29 19:43 -
FogPharma raises $145 million in rare Series E round
2025-09-29 19:35 -
Clinicians often fail to acknowledge the pain caused by long Covid
2025-09-29 19:34 -
Unmasking the 'centricity' illusion in clinical trials
2025-09-29 19:28